This report contains market size and forecasts of Emphysema Drug in global, including the following market information:
Global Emphysema Drug Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Emphysema Drug Market Sales, 2016-2021, 2022-2027, (K Pcs)
Global top five Emphysema Drug companies in 2020 (%)
The global Emphysema Drug market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Emphysema Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Emphysema Drug Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Emphysema Drug Market Segment Percentages, By Type, 2020 (%)
BB-3
EDO-66
MG-53
Others
Global Emphysema Drug Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Emphysema Drug Market Segment Percentages, By Application, 2020 (%)
Hospital
Clinic
Others
Global Emphysema Drug Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Emphysema Drug Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Emphysema Drug revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Emphysema Drug revenues share in global market, 2020 (%)
Key companies Emphysema Drug sales in global market, 2016-2021 (Estimated), (K Pcs)
Key companies Emphysema Drug sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Angion Biomedica Corp.
ProMetic Life Sciences Inc.
rEVO Biologics, Inc.
SATT North SAS
TGV-Laboratories
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Emphysema Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Emphysema Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Emphysema Drug Overall Market Size
2.1 Global Emphysema Drug Market Size: 2021 VS 2027
2.2 Global Emphysema Drug Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Emphysema Drug Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Emphysema Drug Players in Global Market
3.2 Top Global Emphysema Drug Companies Ranked by Revenue
3.3 Global Emphysema Drug Revenue by Companies
3.4 Global Emphysema Drug Sales by Companies
3.5 Global Emphysema Drug Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Emphysema Drug Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Emphysema Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Emphysema Drug Players in Global Market
3.8.1 List of Global Tier 1 Emphysema Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Emphysema Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Emphysema Drug Market Size Markets, 2021 & 2027
4.1.2 BB-3
4.1.3 EDO-66
4.1.4 MG-53
4.1.5 Others
4.2 By Type - Global Emphysema Drug Revenue & Forecasts
4.2.1 By Type - Global Emphysema Drug Revenue, 2016-2021
4.2.2 By Type - Global Emphysema Drug Revenue, 2022-2027
4.2.3 By Type - Global Emphysema Drug Revenue Market Share, 2016-2027
4.3 By Type - Global Emphysema Drug Sales & Forecasts
4.3.1 By Type - Global Emphysema Drug Sales, 2016-2021
4.3.2 By Type - Global Emphysema Drug Sales, 2022-2027
4.3.3 By Type - Global Emphysema Drug Sales Market Share, 2016-2027
4.4 By Type - Global Emphysema Drug Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Emphysema Drug Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Emphysema Drug Revenue & Forecasts
5.2.1 By Application - Global Emphysema Drug Revenue, 2016-2021
5.2.2 By Application - Global Emphysema Drug Revenue, 2022-2027
5.2.3 By Application - Global Emphysema Drug Revenue Market Share, 2016-2027
5.3 By Application - Global Emphysema Drug Sales & Forecasts
5.3.1 By Application - Global Emphysema Drug Sales, 2016-2021
5.3.2 By Application - Global Emphysema Drug Sales, 2022-2027
5.3.3 By Application - Global Emphysema Drug Sales Market Share, 2016-2027
5.4 By Application - Global Emphysema Drug Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Emphysema Drug Market Size, 2021 & 2027
6.2 By Region - Global Emphysema Drug Revenue & Forecasts
6.2.1 By Region - Global Emphysema Drug Revenue, 2016-2021
6.2.2 By Region - Global Emphysema Drug Revenue, 2022-2027
6.2.3 By Region - Global Emphysema Drug Revenue Market Share, 2016-2027
6.3 By Region - Global Emphysema Drug Sales & Forecasts
6.3.1 By Region - Global Emphysema Drug Sales, 2016-2021
6.3.2 By Region - Global Emphysema Drug Sales, 2022-2027
6.3.3 By Region - Global Emphysema Drug Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Emphysema Drug Revenue, 2016-2027
6.4.2 By Country - North America Emphysema Drug Sales, 2016-2027
6.4.3 US Emphysema Drug Market Size, 2016-2027
6.4.4 Canada Emphysema Drug Market Size, 2016-2027
6.4.5 Mexico Emphysema Drug Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Emphysema Drug Revenue, 2016-2027
6.5.2 By Country - Europe Emphysema Drug Sales, 2016-2027
6.5.3 Germany Emphysema Drug Market Size, 2016-2027
6.5.4 France Emphysema Drug Market Size, 2016-2027
6.5.5 U.K. Emphysema Drug Market Size, 2016-2027
6.5.6 Italy Emphysema Drug Market Size, 2016-2027
6.5.7 Russia Emphysema Drug Market Size, 2016-2027
6.5.8 Nordic Countries Emphysema Drug Market Size, 2016-2027
6.5.9 Benelux Emphysema Drug Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Emphysema Drug Revenue, 2016-2027
6.6.2 By Region - Asia Emphysema Drug Sales, 2016-2027
6.6.3 China Emphysema Drug Market Size, 2016-2027
6.6.4 Japan Emphysema Drug Market Size, 2016-2027
6.6.5 South Korea Emphysema Drug Market Size, 2016-2027
6.6.6 Southeast Asia Emphysema Drug Market Size, 2016-2027
6.6.7 India Emphysema Drug Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Emphysema Drug Revenue, 2016-2027
6.7.2 By Country - South America Emphysema Drug Sales, 2016-2027
6.7.3 Brazil Emphysema Drug Market Size, 2016-2027
6.7.4 Argentina Emphysema Drug Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Emphysema Drug Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Emphysema Drug Sales, 2016-2027
6.8.3 Turkey Emphysema Drug Market Size, 2016-2027
6.8.4 Israel Emphysema Drug Market Size, 2016-2027
6.8.5 Saudi Arabia Emphysema Drug Market Size, 2016-2027
6.8.6 UAE Emphysema Drug Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Angion Biomedica Corp.
7.1.1 Angion Biomedica Corp. Corporate Summary
7.1.2 Angion Biomedica Corp. Business Overview
7.1.3 Angion Biomedica Corp. Emphysema Drug Major Product Offerings
7.1.4 Angion Biomedica Corp. Emphysema Drug Sales and Revenue in Global (2016-2021)
7.1.5 Angion Biomedica Corp. Key News
7.2 ProMetic Life Sciences Inc.
7.2.1 ProMetic Life Sciences Inc. Corporate Summary
7.2.2 ProMetic Life Sciences Inc. Business Overview
7.2.3 ProMetic Life Sciences Inc. Emphysema Drug Major Product Offerings
7.2.4 ProMetic Life Sciences Inc. Emphysema Drug Sales and Revenue in Global (2016-2021)
7.2.5 ProMetic Life Sciences Inc. Key News
7.3 rEVO Biologics, Inc.
7.3.1 rEVO Biologics, Inc. Corporate Summary
7.3.2 rEVO Biologics, Inc. Business Overview
7.3.3 rEVO Biologics, Inc. Emphysema Drug Major Product Offerings
7.3.4 rEVO Biologics, Inc. Emphysema Drug Sales and Revenue in Global (2016-2021)
7.3.5 rEVO Biologics, Inc. Key News
7.4 SATT North SAS
7.4.1 SATT North SAS Corporate Summary
7.4.2 SATT North SAS Business Overview
7.4.3 SATT North SAS Emphysema Drug Major Product Offerings
7.4.4 SATT North SAS Emphysema Drug Sales and Revenue in Global (2016-2021)
7.4.5 SATT North SAS Key News
7.5 TGV-Laboratories
7.5.1 TGV-Laboratories Corporate Summary
7.5.2 TGV-Laboratories Business Overview
7.5.3 TGV-Laboratories Emphysema Drug Major Product Offerings
7.5.4 TGV-Laboratories Emphysema Drug Sales and Revenue in Global (2016-2021)
7.5.5 TGV-Laboratories Key News
8 Global Emphysema Drug Production Capacity, Analysis
8.1 Global Emphysema Drug Production Capacity, 2016-2027
8.2 Emphysema Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Emphysema Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Emphysema Drug Supply Chain Analysis
10.1 Emphysema Drug Industry Value Chain
10.2 Emphysema Drug Upstream Market
10.3 Emphysema Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Emphysema Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Emphysema Drug in Global Market
Table 2. Top Emphysema Drug Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Emphysema Drug Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Emphysema Drug Revenue Share by Companies, 2016-2021
Table 5. Global Emphysema Drug Sales by Companies, (K Pcs), 2016-2021
Table 6. Global Emphysema Drug Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Emphysema Drug Price (2016-2021) & (USD/Pcs)
Table 8. Global Manufacturers Emphysema Drug Product Type
Table 9. List of Global Tier 1 Emphysema Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Emphysema Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type
Angion Biomedica Corp.
ProMetic Life Sciences Inc.
rEVO Biologics, Inc.
SATT North SAS
TGV-Laboratories